• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor
    Hero Background

    Legionella Testing Market

    ID: MRFR/HC/31203-HCR
    128 Pages
    Rahul Gotadki
    October 2025

    Legionella Testing Market Research Report By Test Type (Culture Tests, Polymerase Chain Reaction, Antigen Detection Tests, Nucleic Acid Amplification Tests), By Technology (Traditional Methods, Molecular Methods, Immunological Methods), By Sample Type (Water Samples, Environmental Samples, Clinical Samples), By End User (Hospitals, Laboratories, Public Health Organizations, Research Institutions) and By Regional (North America, Europe, South America, Asia-Pacific, Middle East and Africa) - Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Legionella Testing Market Infographic
    Purchase Options

    Legionella Testing Market Summary

    The Global Legionella Testing Market is projected to grow from 0.83 USD Billion in 2024 to 1.47 USD Billion by 2035.

    Key Market Trends & Highlights

    Legionella Testing Key Trends and Highlights

    • The market is expected to experience a compound annual growth rate (CAGR) of 5.36 percent from 2025 to 2034.
    • By 2035, the market valuation is anticipated to reach 1.47 USD Billion, indicating robust growth potential.
    • in 2024, the market is valued at 0.83 USD Billion, reflecting the increasing focus on water quality and safety.
    • Growing adoption of advanced testing technologies due to heightened awareness of Legionella risks is a major market driver.

    Market Size & Forecast

    2024 Market Size 0.83 (USD Billion)
    2035 Market Size 1.47 (USD Billion)
    CAGR (2025-2035) 5.34%

    Major Players

    GE Healthcare, EnviroSuite, Randox Laboratories, Sigma-Aldrich, Merck KGaA, BioRad Laboratories, Neogen Corporation, Thermo Fisher Scientific, Adpath Laboratories, Hach, ASCEM, MilliporeSigma, Cleveland Biolabs, Waters Corporation

    Legionella Testing Market Trends

    The Legionella Testing Market is influenced by several key market drivers that shape its growth and evolution. Increasing awareness about waterborne diseases, particularly in industrial and residential settings, highlights the necessity for reliable testing methods. Stricter regulatory standards for water quality and safety further propel the demand for Legionella testing, as organizations aim to prevent outbreaks and ensure compliance in environments such as healthcare facilities, hotels, and recreational water sources. The rising incidence of pneumonia cases attributed to Legionella also underscores the critical need for effective monitoring and testing practices.As the market evolves, numerous opportunities emerge for stakeholders to explore.

    Advancements in testing technology present a unique chance for companies to innovate and offer solutions that are faster, more accurate, and cost-effective.

    There is a growing demand for point-of-use testing kits that provide real-time results, which can significantly enhance response measures in potentially contaminated environments. Collaboration with public health organizations can also open avenues for spreading awareness and education about the risks of Legionella, leading to increased market penetration. Recent trends indicate a shift towards more integrated testing approaches, combining traditional methods with new technologies such as molecular testing and automated systems that streamline the testing process.

    Additionally, the pandemic has heightened the focus on environmental monitoring, making indoor air and water safety paramount. This trend is orchestrating a surge in demand for comprehensive testing solutions as organizations prioritize the health of occupants and compliance with safety regulations. As the market navigates these dynamics, understanding consumer needs and regulatory landscapes will be essential for capitalizing on growth opportunities.

     

    Source Primary Research, Secondary Research, Market Research Future Database and Analyst Review

    The increasing awareness of public health risks associated with Legionella bacteria is driving a notable expansion in testing protocols across various sectors, particularly in healthcare and hospitality.

    U.S. Environmental Protection Agency (EPA)

    Legionella Testing Market Drivers

    Market Growth Projections

    The Global Legionella Testing Market Industry is projected to experience substantial growth over the coming years. With an anticipated market size of 0.83 USD Billion in 2024, it is expected to reach 1.47 USD Billion by 2035, reflecting a robust CAGR of 5.36% from 2025 to 2035. This growth trajectory indicates a rising demand for Legionella testing services and products, driven by factors such as increased awareness, regulatory compliance, and technological advancements. The market's expansion is indicative of a broader commitment to public health and safety, as organizations prioritize the prevention of Legionnaires disease.

    Rising Healthcare Expenditure

    An increase in global healthcare expenditure is positively impacting the Global Legionella Testing Market Industry. As governments and private sectors allocate more resources to healthcare, there is a growing emphasis on preventive measures, including water quality testing. Enhanced funding for public health initiatives allows for more comprehensive testing programs, which are essential in identifying and mitigating Legionella risks. This trend is expected to foster market growth, as healthcare systems prioritize the prevention of waterborne diseases. The focus on health and safety is likely to drive demand for Legionella testing services and products.

    Regulatory Compliance and Standards

    Stringent regulatory frameworks and standards imposed by health authorities globally are significantly influencing the Global Legionella Testing Market Industry. Governments are establishing guidelines that mandate regular testing of water systems in commercial and residential buildings to prevent Legionella proliferation. Compliance with these regulations not only ensures public safety but also protects organizations from potential legal liabilities. As the market adapts to these evolving standards, it is anticipated to grow at a CAGR of 5.36% from 2025 to 2035, ultimately reaching 1.47 USD Billion by 2035. This regulatory environment fosters a culture of safety and accountability.

    Increasing Awareness of Legionella Risks

    The rising awareness regarding the health risks associated with Legionella bacteria is a primary driver for the Global Legionella Testing Market Industry. Public health campaigns and educational initiatives emphasize the dangers of Legionnaires disease, which can arise from contaminated water systems. As a result, organizations and facilities are increasingly prioritizing water quality testing to ensure safety. This heightened awareness is reflected in the projected market growth, with the Global Legionella Testing Market expected to reach 0.83 USD Billion in 2024. Such proactive measures are essential in mitigating outbreaks and protecting public health.

    Technological Advancements in Testing Methods

    Innovations in testing technologies are propelling the Global Legionella Testing Market Industry forward. Advanced methodologies, such as PCR (Polymerase Chain Reaction) and rapid culture techniques, enhance the accuracy and speed of Legionella detection. These technological advancements enable quicker response times in identifying contamination, thereby reducing the risk of outbreaks. As testing becomes more efficient, organizations are likely to increase their testing frequency, further driving market growth. The integration of these technologies is expected to play a crucial role in the market's evolution, aligning with the increasing demand for reliable testing solutions.

    Growth in Water Treatment and Management Sectors

    The expansion of water treatment and management sectors is a notable driver for the Global Legionella Testing Market Industry. As urbanization and industrialization continue to rise, the demand for effective water management solutions increases correspondingly. This growth necessitates regular testing for Legionella to ensure that water systems remain safe and compliant with health standards. The market is poised for growth as industries invest in advanced water treatment technologies and practices. This trend is likely to contribute to the market's expansion, as organizations recognize the importance of maintaining water quality to prevent health risks.

    Market Segment Insights

    Legionella Testing Market Test Type Insights  

    In 2023, the Legionella Testing Market was valued at 0.75 USD Billion, showcasing a steady demand for effective testing methodologies across various segments, particularly in the Test Type category. The Culture Tests held a dominant position within this market segment, valued at 0.3 USD Billion, and expected to rise to 0.5 USD Billion by 2032. This methodology is significant as it allows for the identification and quantification of Legionella bacteria in water samples, which is crucial for ensuring water quality and public health safety.

    Following Culture Tests, the Polymerase Chain Reaction (PCR) testing segment is also noteworthy, valued at 0.2 USD Billion in 2023 and projected to grow to 0.35 USD Billion by 2032.PCR is vital for its rapid, accurate, and sensitive detection capabilities, making it an essential tool in clinical diagnostics and environmental monitoring. The Antigen Detection Tests segment, valued at 0.15 USD Billion in 2023, is also important, forecasted to increase to 0.25 USD Billion by 2032. This method is valued for its quick turnaround times, providing timely results essential in outbreak situations.

    Lastly, the Nucleic Acid Amplification Tests segment accounted for 0.1 USD Billion in 2023 and is expected to reflect growth to 0.2 USD Billion by 2032.While this segment currently holds the least value compared to the others, its relevance lies in its ability to precisely detect genetic material from Legionella, making it a promising area for future developments and innovations. The overall landscape of the Legionella Testing Market shows substantial possibilities for growth, driven by increasing awareness of waterborne diseases, regulatory requirements for water testing, and advancements in testing technologies.

    Legionella Testing Market Technology Insights  

    The Legionella Testing Market reached a valuation of 0.75 billion USD in 2023 and is projected to grow significantly by 2032. The market growth is driven by the rising demand for effective testing methodologies to ensure public safety from Legionella outbreaks. Within this market, technology plays a crucial role, particularly in Traditional Methods, Molecular Methods, and Immunological Methods.

    Traditional Methods remain essential for their established protocols and reliability in testing, while Molecular Methods offer greater sensitivity and faster results, becoming increasingly adopted in clinical and environmental testing.Immunological Methods present a significant avenue as they often allow rapid detection of Legionella species, aligning with the growing urgency for quick response in public health scenarios. Collectively, these testing technologies cater to diverse needs, showcasing the Legionella Testing Market's segmentation dynamics while addressing the escalating concern for waterborne pathogens and the regulatory pressures influencing market trends.

    With rising awareness and technological advancements, the Legionella Testing Market statistics reveal a promising outlook for the various methodologies employed in detecting Legionella.

    Legionella Testing Market Sample Type Insights  

    The Legionella Testing Market is witnessing substantial growth, with a market valuation of 0.75 billion USD in 2023. This growth is underpinned by the importance of various sample types, particularly Water Samples, Environmental Samples, and Clinical Samples. Water Samples hold a significant share in testing, driven by the frequent testing in various sectors, including residential, commercial, and industrial, to combat waterborne diseases. Environmental Samples are also vital, as they assess potential Legionella contamination in natural and engineered water systems.Clinical Samples facilitate the diagnosis of Legionnaires' disease, ensuring timely treatment.

    The combined emphasis on these sample types showcases a robust market structure, where the persistent focus on public health is propelling the demand for effective Legionella testing solutions. The trend towards stringent regulations and standards for water quality further enhances the relevance of these samples within the Legionella Testing Market. As the market evolves, opportunities lie in technological advancements that improve the speed and accuracy of testing methodologies across these critical sample types.

    Legionella Testing Market End User Insights  

    The Legionella Testing Market is valued at 0.75 billion USD in 2023 and is expected to exhibit notable growth over the coming years. The market segmentation highlights a diverse range of End Users, including Hospitals, Laboratories, Public Health Organizations, and Research Institutions. Hospitals play a crucial role in the detection and management of Legionella due to their responsibility for patient care and safety. Similarly, Laboratories are integral as they are primary facilities for conducting tests, thus holding a significant market share.Public Health Organizations contribute with their objective of managing community health and preventing outbreaks, directly impacting testing demand.

    Research Institutions also bolster the market by advancing studies related to Legionella pathogen detection and control methodologies. Together, these End Users underscore the importance of the Legionella Testing Market revenue, driven by rising awareness of healthcare safety and increasing regulatory requirements for water quality testing, thus spurring overall market growth.

    Get more detailed insights about Legionella Testing Market

    Regional Insights

    The Legionella Testing Market revenue is expected to showcase a steady growth trend across its regional segments, with North America holding the majority share. In 2023, North America was valued at 0.3 USD Billion, increasing to 0.48 USD Billion by 2032, showcasing its significant demand for effective Legionella testing solutions. Europe follows suit, valued at 0.2 USD Billion in 2023 and anticipated to rise to 0.32 USD Billion by 2032, indicating its notable focus on water safety regulations.

    The APAC region stands at 0.15 USD Billion in 2023 and is set to grow to 0.24 USD Billion, driven by increasing urbanization and industrial development necessitating better testing measures.South America and MEA both begin at 0.05 USD Billion in 2023, with projections of reaching 0.08 USD Billion by 2032. Although these regions exhibit smaller market sizes, the growing awareness regarding waterborne pathogens presents opportunities for market expansion. Collectively, these figures highlight the Legionella Testing Market data across regions, emphasizing the varying degrees of market penetration, consumer awareness, and regulatory factors influencing market growth.

    Moreover, the statistics reflect both challenges and opportunities within these regions, notably the industrial development in APAC and the stringent regulations in Europe, which drive the need for advanced testing solutions.

    Legionella Testing Market By Regional (North America)

    Source Primary Research, Secondary Research, Market Research Future Database and Analyst Review

    Key Players and Competitive Insights

    The Legionella Testing Market is characterized by a diverse and competitive landscape, driven by the increasing need for testing solutions due to rising health concerns associated with Legionella bacteria. As regulatory standards tighten and awareness about Legionnaires' disease grows, several key players are actively engaged in developing advanced testing methodologies, enhancing product offerings, and expanding their geographical footprint. Innovation, particularly in rapid testing technologies and accurate detection methods, plays a pivotal role in shaping the competition. Companies in this market are also focusing on strategic collaborations and partnerships, influencing their market positioning and visibility.

    Overall, the competitive insights within this market highlight a race towards efficiency, accuracy, and reliability in Legionella detection, with a commitment to improving public health safety.GE Healthcare is recognized as a significant player within the Legionella Testing Market, leveraging its extensive experience in healthcare technology to offer advanced diagnostic solutions. 

    The company has established a strong presence in the market by providing innovative testing platforms that ensure rapid and precise detection of Legionella bacteria. GE Healthcare's strengths lie in its commitment to research and development, continuous improvement of its testing methods, and integration of cutting-edge technology into its products. Their robust distribution networks and established customer relationships further enhance their competitive edge. 

    The company's focus on quality and compliance with health and safety regulations supports its credibility and trustworthiness in the market, positioning it favorably in scenarios demanding comprehensive testing and analysis for Legionella.EnviroSuite has carved out a notable niche within the Legionella Testing Market by focusing on environmental monitoring and management solutions. Its strengths lie in the company's advanced analytical tools and technologies that provide reliable data for environmental health assessments, including Legionella surveillance. EnviroSuite employs innovative strategies, utilizing real-time data analytics to enhance the effectiveness of water quality monitoring and to deliver actionable insights for risk management.

    Moreover, the company's commitment to customer-centric solutions and adaptability to evolving regulatory requirements enhances its appeal in the market. By fostering partnerships with various stakeholders, EnviroSuite fortifies its position as an essential contributor to Legionella testing initiatives, aiming to improve public health outcomes through proactive environmental management solutions.

    Key Companies in the Legionella Testing Market market include

    Industry Developments

    • Q2 2024: IDEXX Launches Legiolert Test for Rapid Detection of Legionella pneumophila in Water IDEXX announced the launch of its Legiolert test, designed to rapidly detect Legionella pneumophila in water samples, aiming to improve public health safety and compliance with water testing regulations.
    • Q1 2024: QuidelOrtho Corporation Receives CE Mark for Sofia Legionella FIA Test QuidelOrtho Corporation received CE Mark approval for its Sofia Legionella FIA test, enabling the company to market the product in the European Union for rapid detection of Legionella antigens in clinical samples.
    • Q2 2024: Thermo Fisher Scientific Expands Legionella Testing Portfolio with New PCR Assay Thermo Fisher Scientific announced the expansion of its Legionella testing portfolio by launching a new PCR assay, designed to provide faster and more accurate detection of Legionella species in water systems.
    • Q2 2024: Bio-Rad Laboratories Announces Partnership with European Water Utility for Legionella Monitoring Bio-Rad Laboratories entered into a partnership with a major European water utility to supply Legionella testing kits and support ongoing monitoring programs to prevent outbreaks in municipal water systems.
    • Q1 2024: Qiagen Launches New Automated Legionella Testing Platform Qiagen launched a new automated platform for Legionella testing, aiming to streamline laboratory workflows and improve the speed and reliability of Legionella detection in environmental samples.
    • Q2 2024: Eiken Chemical Co., Ltd. Announces Expansion of Legionella Test Production Facility in Japan Eiken Chemical Co., Ltd. announced the opening of an expanded production facility in Japan dedicated to manufacturing Legionella test kits, responding to increased demand for water safety testing.
    • Q1 2025: Pro-Lab Diagnostics Receives UK Regulatory Approval for New Legionella Rapid Test Pro-Lab Diagnostics received regulatory approval in the UK for its new rapid Legionella test, allowing the company to market the product to healthcare and environmental testing laboratories.
    • Q2 2025: Abbott Laboratories Launches Next-Generation Legionella Detection System Abbott Laboratories launched a next-generation Legionella detection system, featuring enhanced sensitivity and faster turnaround times for water testing in commercial and healthcare settings.
    • Q1 2025: QuidelOrtho Corporation Announces Strategic Partnership with US Hospital Network for Legionella Surveillance QuidelOrtho Corporation announced a strategic partnership with a large US hospital network to implement Legionella surveillance programs using its diagnostic products.
    • Q2 2024: Thermo Fisher Scientific Acquires Small Diagnostics Firm Specializing in Legionella Testing Thermo Fisher Scientific completed the acquisition of a diagnostics firm specializing in Legionella testing, aiming to strengthen its position in the waterborne pathogen detection market.
    • Q1 2024: IDEXX Receives US EPA Approval for Legiolert Test Method IDEXX received approval from the US Environmental Protection Agency (EPA) for its Legiolert test method, allowing its use in official water quality monitoring programs.
    • Q2 2025: Bio-Rad Laboratories Announces $20 Million Investment to Expand Legionella R&D Bio-Rad Laboratories announced a $20 million investment to expand research and development efforts focused on new Legionella detection technologies and products.

    Future Outlook

    Legionella Testing Market Future Outlook

    The Legionella Testing Market is projected to grow at a 5.34% CAGR from 2024 to 2034, driven by increasing regulatory requirements, heightened public health awareness, and technological advancements in testing methods.

    New opportunities lie in:

    • Develop rapid testing kits for on-site analysis in commercial buildings. Invest in AI-driven data analytics for predictive maintenance of water systems. Expand service offerings to include comprehensive risk assessment and management solutions.

    By 2035, the Legionella Testing Market is expected to be robust, reflecting enhanced safety protocols and technological integration.

    Market Segmentation

    Legionella Testing Market End User Outlook

    • Hospitals
    • Laboratories
    • Public Health Organizations
    • Research Institutions

    Legionella Testing Market Regional Outlook

    • North America
    • Europe
    • South America
    • Asia-Pacific
    • Middle East and Africa

    Legionella Testing Market Test Type Outlook

    • Culture Tests
    • Polymerase Chain Reaction
    • Antigen Detection Tests
    • Nucleic Acid Amplification Tests

    Legionella Testing Market Technology Outlook

    • Traditional Methods
    • Molecular Methods
    • Immunological Method

    Legionella Testing Market Sample Type Outlook

    • Water Samples
    • Environmental Samples
    • Clinical Samples

    Report Scope

    Report Attribute/MetricDetails
    Market Size 2024   0.83 (USD Billion)
    Market Size 2025   0.87 (USD Billion)
    Market Size 20351.47 (USD Billion)
    Compound Annual Growth Rate (CAGR)5.34% (2025 - 2035)
    Report CoverageRevenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Base Year2024
    Market Forecast Period2025 - 2035
    Historical Data2020 - 2024
    Market Forecast UnitsUSD Billion
    Key Companies ProfiledGE Healthcare, EnviroSuite, Randox Laboratories, Sigma-Aldrich, Merck KGaA, BioRad Laboratories, Neogen Corporation, Thermo Fisher Scientific, Adpath Laboratories, Hach, ASCE, MilliporeSigma, Cleveland Biolabs, Waters Corporation
    Segments CoveredTest Type, Technology, Sample Type, End User, Regional
    Key Market OpportunitiesRising awareness of waterborne diseases, Stringent regulatory guidelines enforcement, Technological advancements in testing methods, Expansion of healthcare facilities, and Increasing demand for environmental monitoring.
    Key Market DynamicsIncreasing waterborne disease outbreaks, Growing regulatory compliance requirements, Advancements in testing technologies, Rising public awareness of Legionella, Expanding applications in healthcare facilities
    Countries CoveredNorth America, Europe, APAC, South America, MEA

    FAQs

    What is the projected growth of the Legionella Testing market?

    The Legionella Testing market is the expected increase in total market value of 1.47 USD billion over a defined forecast period 2025–2035. It is driven by factors such as demand trends, technological advances, regulatory changes, and geographic expansion.

    What is the size of the Legionella Testing market?

    Legionella Testing market size was valued at approximately 0.83 billion USD in 2024. This figure will reach 1.47 billion USD covering all regions (America, Europe, Asia, MEA and ROW), focusing its segments / services / distribution channels till 2035.

    What is the CAGR of the Legionella Testing market?

    Legionella Testing market is expected to grow at a CAGR of 5.34% between 2025 and 2035.

    How much will the Legionella Testing market be worth by 2035?

    Legionella Testing market is expected to be worth of 1.47 billion USD, reflecting growth driven by usage, technology and global demands by the end of 2035.

    How will the Legionella Testing market perform over the next 10 years?

    Over the next 10 years the Legionella Testing market is expected to shift from usd billion 0.83 to 1.47 billion USD, led by adoption of advanced tech, demographic trends, regulatory approvals, with potential headwinds from 2025 to 2035.

    Which region holds the largest market share in the Legionella Testing Market in 2024?

    In 2024, North America holds the largest market share, valued at 0.3 USD Billion.

    How much is the market size of the Legionella Testing Market in Europe in 2035?

    The market size in Europe is expected to be 0.32 USD Billion in 2035.

    Which key player has a significant presence in the Legionella Testing Market?

    Major players in the market include GE Healthcare, Thermo Fisher Scientific, and Merck KGaA.

    What is the growth rate of the Nucleic Acid Amplification Tests segment from 2025 to 2035?

    The Nucleic Acid Amplification Tests segment is expected to grow significantly, reaching 0.2 USD Billion by 2035.

    How much is the Legionella Testing Market in the APAC region projected to grow by 2035?

    The market size in the APAC region is anticipated to grow to 0.24 USD Billion by 2035.

    Download Free Sample

    Kindly complete the form below to receive a free sample of this Report

    Case Study
    Chemicals and Materials